Therapeutic Exploratory Study of CWP-0403

Summary

Objective of the trial is to assess dose-dependency, efficacy and safety and to estimate optimum dosage for confirmatory study of CWP-0403 50mg, 100mg given twice daily for 12 weeks to type 2 diabetes patients who are insufficiently controlled by diet and exercise in comparison to placebo.

Timeline

Start

2009-02

Primary completion

2010-01

Completion

2010-04

Drugs

Indications